Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-022392

Director bought 117 shares at $5.29 ($619)

From the SEC's structured data for this filing

Trades in this filing

Peyer James · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-17 Purchase : show line 1 in the form +117 $5.29 $619 4,823,286 I
Open-market purchases · 117 sh · avg $5.29 · $619
Loading xslF345X03/doc1.xml…